HOME > Investors > Press Releases
2017-06-13
[Dong-A Business Review] ViroMed - 1st generation Bio-Venture in Korea and its growth strategy
2017-05-25
2017.05(IR letter) Business Updates
2017-04-04
2016 Annual Report
2017-03-06
2016.06 (IR letter) Business Updates
2017-02-10
VM BioPharma Announces Publication of Phase 1/2 Clinical Data of Novel Gene Therapy VM202 in Amyotrophic Lateral Sclerosis (ALS)
1 2 3 4 5 6 7 8 9 10